- Home
- XXII vs SSY Comparison
XXII vs SSY Comparison
Compare XXII & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- SSY
- Stock Information
- Founded
- XXII 1998
- SSY 1959
- Country
- XXII United States
- SSY United States
- Employees
- XXII N/A
- SSY N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- SSY Hospital/Nursing Management
- Sector
- XXII Health Care
- SSY Health Care
- Exchange
- XXII Nasdaq
- SSY Nasdaq
- Market Cap
- XXII 7.0M
- SSY 6.2M
- IPO Year
- XXII N/A
- SSY N/A
- Fundamental
- Price
- XXII $8.09
- SSY $0.88
- Analyst Decision
- XXII
- SSY
- Analyst Count
- XXII 0
- SSY 0
- Target Price
- XXII N/A
- SSY N/A
- AVG Volume (30 Days)
- XXII 37.6K
- SSY 192.4K
- Earning Date
- XXII 08-12-2025
- SSY 05-13-2025
- Dividend Yield
- XXII N/A
- SSY N/A
- EPS Growth
- XXII N/A
- SSY N/A
- EPS
- XXII N/A
- SSY 0.25
- Revenue
- XXII $23,869,000.00
- SSY $31,094,000.00
- Revenue This Year
- XXII $22.41
- SSY N/A
- Revenue Next Year
- XXII $76.35
- SSY N/A
- P/E Ratio
- XXII N/A
- SSY $3.57
- Revenue Growth
- XXII N/A
- SSY N/A
- 52 Week Low
- XXII $6.28
- SSY $0.62
- 52 Week High
- XXII $2,837.04
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- XXII 24.50
- SSY 41.55
- Support Level
- XXII $6.81
- SSY $0.95
- Resistance Level
- XXII $9.50
- SSY $1.06
- Average True Range (ATR)
- XXII 1.70
- SSY 0.09
- MACD
- XXII -0.32
- SSY -0.01
- Stochastic Oscillator
- XXII 20.46
- SSY 11.21
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.